Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
Clinical trial NCT03368729 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03368729
- Sponsor
- University of Alabama at Birmingham
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2027-11-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.